Published in Am J Drug Alcohol Abuse on January 01, 2006
Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl) (2011) 1.04
Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics. Am J Drug Alcohol Abuse (2009) 0.97
Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use. Drug Alcohol Depend (2011) 0.88
Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug Alcohol Depend (2009) 0.79
The influence of baseline marijuana use on treatment of cocaine dependence: application of an informative-priors bayesian approach. Front Psychiatry (2012) 0.77
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. Am J Addict (2016) 0.75
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet (2011) 6.35
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA (2004) 4.12
Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv (2007) 3.38
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr (2008) 2.78
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend (2007) 2.63
Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry (2009) 2.44
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol (2010) 2.36
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol (2009) 2.26
Organizational Readiness for Change and opinions toward treatment innovations. J Subst Abuse Treat (2007) 2.14
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res (2011) 2.10
Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (2007) 1.97
Use of artificial tanning products among young adults. J Am Acad Dermatol (2006) 1.91
Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychol Addict Behav (2008) 1.72
Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend (2007) 1.64
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness. Addiction (2013) 1.63
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J Bone Miner Res (2015) 1.60
Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat (2007) 1.57
Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet (2007) 1.54
Treatment of cannabis use disorders: a review of the literature. Am J Addict (2007) 1.48
Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. Am J Drug Alcohol Abuse (2011) 1.44
Maternal birthplace and breastfeeding initiation among term and preterm infants: a statewide assessment for Massachusetts. Pediatrics (2006) 1.44
Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend (2006) 1.42
Mycobacterium tuberculosis and the host response. J Exp Med (2005) 1.40
Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am J Psychiatry (2014) 1.40
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Behavioral naltrexone therapy: an integrated treatment for opiate dependence. J Subst Abuse Treat (2002) 1.36
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol Cancer Ther (2011) 1.33
A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31
The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav (2009) 1.28
Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend (2008) 1.25
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend (2005) 1.18
Treatment of depression in patients with opiate dependence. Biol Psychiatry (2004) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway. Cancer Res (2014) 1.14
Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2008) 1.13
Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis. J Biol Chem (2012) 1.12
Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am (2012) 1.12
Management of relapse in naltrexone maintenance for heroin dependence. Drug Alcohol Depend (2007) 1.11
Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial. Am J Addict (2006) 1.11
A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res (2007) 1.11
Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology (Berl) (2002) 1.10
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry (2011) 1.10
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10
Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse (2011) 1.10
Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.09
Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs. Am J Drug Alcohol Abuse (2009) 1.09
Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08
Relationship power and sexual risk among women in community-based substance abuse treatment. J Urban Health (2009) 1.07
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav (2008) 1.06
Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06
Training physicians to treat substance use disorders. Curr Psychiatry Rep (2008) 1.06
Providing live supervision via teleconferencing improves acquisition of motivational interviewing skills after workshop attendance. Am J Drug Alcohol Abuse (2007) 1.05
The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders. Harv Rev Psychiatry (2009) 1.05
Uses of coercion in addiction treatment: clinical aspects. Am J Addict (2008) 1.04
Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) (2011) 1.04
Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abus (2006) 1.04
Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2010) 1.04
Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse (2005) 1.04
"Old dogs" and new skills: how clinician characteristics relate to motivational interviewing skills before, during, and after training. J Consult Clin Psychol (2012) 1.03
Modafinil does not serve as a reinforcer in cocaine abusers. Drug Alcohol Depend (2009) 1.02
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. Am J Addict (2009) 1.02
Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav (2004) 1.02
Alcohol increases impulsivity and abuse liability in heavy drinking women. Exp Clin Psychopharmacol (2012) 1.02
Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology (2006) 1.01
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (2013) 1.01
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend (2010) 1.01
OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend (2010) 1.01
Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study. Am J Drug Alcohol Abuse (2009) 1.01
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. J Subst Abuse Treat (2006) 1.00
Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res (2008) 1.00